Development of an Automated Tool for the Estimation of Histological Remission in Ulcerative Colitis Using Single-Wavelength Endoscopy Technology - Scorecard - MDSpire
Advertisement
Development of an Automated Tool for the Estimation of Histological Remission in Ulcerative Colitis Using Single-Wavelength Endoscopy Technology
Clinical Scorecard: Creation of an Automated System for Assessing Histological Remission in Ulcerative Colitis Utilizing Single-Wavelength Endoscopy Techniques
At a Glance
Category
Detail
Condition
Ulcerative colitis (UC)
Key Mechanisms
Assessment of histological remission via microvascular changes detected by single-wavelength endoscopy (SWE) and computer-aided diagnosis (CAD) using deep learning
Target Population
Patients with histologically confirmed UC with minimum disease duration of 3 months
Care Setting
Endoscopy units performing colonoscopy or flexible sigmoidoscopy
Key Highlights
SWE-CAD model demonstrated superior diagnostic accuracy (95.2%) for histological remission compared to WLE-CAD (67.5%)
SWE uses 410 nm monochromatic light to visualize mucosal microvasculature and subtle histological inflammation in vivo
Automated CAD reduces inter-reader variability and provides objective assessment of histological remission in UC
Guideline-Based Recommendations
Diagnosis
Use colonoscopy or flexible sigmoidoscopy with both WLE and SWE imaging modalities for UC disease activity assessment
Obtain biopsies at imaged sites for histological confirmation using Geboes score
Apply CAD models trained on SWE images to estimate histological remission non-invasively
Management
Target histological remission as a treatment goal in UC management
Incorporate SWE-CAD assessment to guide therapeutic decisions by accurately detecting histological activity
Monitoring & Follow-up
Perform regular endoscopic evaluations with SWE imaging to monitor mucosal healing and histological remission
Use CAD outputs to reduce variability and improve consistency in disease activity monitoring
Risks
Potential for misclassification with WLE alone due to limited sensitivity and specificity for histological activity
Standard biopsy risks apply during tissue sampling for histological confirmation
Patient & Prescribing Data
Patients with UC undergoing endoscopic evaluation
Accurate detection of histological remission via SWE-CAD may optimize treatment adjustments and improve long-term outcomes by targeting deeper mucosal healing
Clinical Best Practices
Utilize high-definition endoscopes capable of both WLE and SWE imaging for comprehensive mucosal assessment
Ensure biopsy sampling is precisely correlated with imaging locations to validate CAD findings
Train and validate CAD models on large datasets to enhance diagnostic performance
Incorporate SWE-CAD assessment into routine clinical workflows to reduce inter-observer variability
by Pieter Sinonquel, Matthias Lenfant, Tom Eelbode, Hiroki Watanabe, Belian Callaerts, Peter Bossuyt, Bram Verstockt, João Pedro Guedelha Sabino, Gert De Hertogh, Frederik Maes, Séverine Vermeire, Raf Bisschops